ENvue Medical, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-4.9M | $-3.8M | $-12.9M | $510.0K | $-4.0M | $-1.9M | $-1.4M | $-998.0K |
| Depreciation & Amortization | $219.0K | $217.0K | $258.0K | $257.0K | $364.0K | $18.0K | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $209.0K | $210.0K | — | — | $347.0K | $17.0K | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | $191.0K | $58.0K |
| Net Cash from Operating Activities | $-2.7M | $-4.3M | $-2.7M | $-2.0M | $-3.4M | $-1.3M | $-548.0K | $-836.0K |
| Investing Activities | ||||||||
| Capital Expenditures | $27.0K | $17.0K | $23.0K | $28.0K | $4.0K | $5.0K | $0 | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-27.0K | $-17.0K | $-23.0K | $-28.0K | $-4.0K | $143.0K | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.6M | $2.3M | $-34.0K | $4.9M | $6.9M | $1.1M | — | — |
| Net Change in Cash | $-1.1M | $-2.0M | $-2.7M | $2.9M | $3.5M | $-151.0K | $-553.0K | $-865.0K |
| Free Cash Flow | $-2.7M | $-4.3M | $-2.7M | $-2.0M | $-3.4M | $-1.3M | $-548.0K | $-836.0K |